Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigamox in Pediatric Bacterial Conjunctivitis
NCT00312338Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Moxisurge in bacterial conjunctivitis (BC), sponsored by Alcon Inc.. Started Jun 2006; status: completed.
02
Drugs
Moxisurge
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00312338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312338.